Geetanjali Credit Fixes ₹88.38 Crore Rights Issue Terms
Key highlights
- Geetanjali Credit's rights issue offers 7,07,07,200 partly paid-up equity shares at ₹12.50 each.
- The rights issue can raise up to ₹88.38 crore, assuming full subscription and payment of call monies.
- Eligible holders receive 16 rights shares for every 1 fully paid-up share held on November 18, 2026.
- Rights Entitlements trade from November 27 to December 2, 2026, while subscriptions close on December 7, 2026.
powered by IRIS

Geetanjali Credit and Capital Limited has fixed an ₹88.38 crore rights issue of 7,07,07,200 partly paid-up equity shares at ₹12.50 each, with eligible shareholders entitled to 16 rights shares for every one fully paid-up share held on November 18, 2026. The offer opens on November 27 and closes on December 7, 2026.
Know Geetanjali Credit and Capital inside out
Results, valuation, peers and who's buying, in one view.
What are the terms of Geetanjali Credit's rights issue?
Geetanjali Credit has approved a rights offer of 7,07,07,200 partly paid-up equity shares with a face value of ₹10 each and an issue price of ₹12.50 per share. The price includes a premium of ₹2.50 per share over the face value. Assuming full subscription and payment of call monies, the company can raise up to ₹88.38 crore.
The entitlement ratio is 16 rights equity shares for every one fully paid-up equity share held on the record date. This is a large proposed expansion in the company's equity base. The number of equity shares would rise from 44,19,200 before the issue to 7,51,26,400 after the issue, assuming full subscription and payment of call monies.
Who is eligible for the Geetanjali Credit rights offer?
Shareholders who held Geetanjali Credit shares on November 18, 2026 are eligible to receive Rights Entitlements, or REs, under the offer. The company fixed November 18 as the record date for determining eligibility. The entitlement is based on the number of fully paid-up equity shares held on that date.
Rights Entitlements are not the same as allotted equity shares. An eligible investor receives the entitlement to apply for rights shares, but must submit an application and pay the applicable issue price to subscribe. The company has stated that an investor must apply for the shares using the REs and pay ₹12.50 per share.
The company said its Letter of Offer will provide further details of the issue, including the treatment of fractional entitlements. The Letter of Offer is to be filed with the Securities and Exchange Board of India and BSE. The announcement was made under Regulations 30 and 42 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
When can investors trade and subscribe to the rights issue?
Investors can trade Geetanjali Credit Rights Entitlements from November 27, 2026 until December 2, 2026, while the subscription window remains open from November 27 through December 7, 2026. The different deadlines are important because RE trading ends before the subscription period closes.
The record date preceded the opening of both RE trading and the subscription period. Investors who were not eligible on the record date may purchase REs during the specified trading window, subject to market availability. Holding or buying REs does not itself complete a subscription application.
Got a follow-up? Ask IRIS
How can shareholders apply for Geetanjali Credit rights shares?
Shareholders can apply for Geetanjali Credit rights shares through Online ASBA, the online RWAP facility provided by the company's registrar and transfer agent, or physical ASBA through an eligible bank branch. Online ASBA is available where an investor's bank supports the application process, similar to an online initial public offering application.
The Registrar and Transfer Agent's RWAP facility is another online route for submitting an application. Investors using the offline method need to complete a physical ASBA application form. The form may be received from the registrar by email, courier or speed post and must be submitted at a Self-Certified Syndicate Bank branch if the bank does not support online ASBA.
The issue involves partly paid-up equity shares, and the stated issue terms refer to full subscription and payment of call monies for the maximum issue size and post-issue share count. Investors should therefore review the Letter of Offer for the detailed terms, including any information on payment obligations and fractional entitlements.
Why does the rights issue matter for Geetanjali Credit shareholders?
The rights issue matters because the proposed 7,07,07,200 new shares are substantially higher than Geetanjali Credit's pre-issue base of 44,19,200 shares. A shareholder who does not participate may hold a smaller proportion of the expanded equity capital if the offer is fully subscribed and call monies are paid.
The final terms were approved by the Rights Issue Committee on November 12, 2026. They followed the board's approval on July 16, 2026 to raise up to ₹90 crore through a rights issue. BSE had granted in-principle approval on October 16, 2026, according to the supplied company filing summary.
Geetanjali Credit is a non-deposit-taking non-banking financial company founded in December 1990. Its stated activities include corporate loans, financing, inter-corporate investments and capital market-related activities. The company is offering the new shares to existing shareholders through a rights offer rather than through a public offer.
Conclusion
Geetanjali Credit has set the commercial terms and timetable for an ₹88.38 crore rights issue priced at ₹12.50 per share. The 16-for-1 entitlement ratio, combined with the potential increase in equity shares from 44,19,200 to 7,51,26,400, makes participation decisions relevant for eligible shareholders assessing their proportional holding.
The next scheduled milestones are the opening of RE trading and subscription on November 27, the end of RE trading on December 2, and the subscription closure on December 7, 2026. Shareholders should review the Letter of Offer for the detailed application process, fractional entitlement treatment and other issue conditions.


